Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
W.F. Klietmann, K.L. Ruoff.
Bioterrorism: Implications for the clinical Microbiologist.
Clin Microb Rev, 14 (2001), pp. 364-381
[2.]
D.W. Siegrist.
The Threat of Biological Attack: Why Concern Now?.
Emerg Infect Dis, 5 (1999), pp. 505-508
[3.]
G.W. Christopher, T.J. Cieslak, J.A. Paulin, E.M. Eitzen.
Biological warfare: a histological perspective.
JAMA, 278 (1997), pp. 412-417
[4.]
J.B. Tucker.
Historical Trends related to Bioterrorism: an empirical analysis.
Emerg Infect Dis, 5 (1999), pp. 498-504
[5.]
Centers for Disease Control and Prevention and National Institutes of Health.
Basic Laboratory protocols. Biosafety in Microbiological and Biomedical Laboratories (4th ed).
[6.]
M.G. Kortepeter, G.W. Parker.
Potential biological weapons threats.
Emerg Infect Dis, 34 (1999), pp. 815-826
[7.]
T.C. Dixon, M. Meselson, J. Guillemin, P.G. Hanna.
Anthrax.
New Engl Med, 34 (1999), pp. 815-826
[8.]
T.W. Inglesby, D.A. Henderson, J.G. Bartlett, M.S. Ascher, E. Eitzen, A.M. Friedlander, et al.
Anthrax as a Biological Weapon.
JAMA, 281 (1999), pp. 1735-1745
[9.]
Exodus 9: 1-12.
[10.]
T.J. Cieslak, E.M. Eitzen.
Clinical and Epidemiologic Principles of Anthrax.
Emerg Infect Dis, 5 (1999), pp. 552-555
[11.]
A. Friedlander.
Anthrax.
Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare, pp. 467-478
Copyright © 2002. Elsevier España, S.L. y Sociedad Española de Medicina Rural y Generalista (SEMERGEN)
